• In the media
  • GSK, J&J, Mylan leading much-needed antibioti...
Media - published on 23 Jan 2018

GSK, J&J, Mylan leading much-needed antibiotic R&D efforts, new index finds

Sarah Owermohles reports for S&P Global Market Intelligence on the companies that are most active in addressing antimicrobial resistance.

The article covers the Antimicrobial Resistance Benchmark, focusing on the key findings on the performance of large research-based pharmaceutical companies, generic medicine manufacturers and biopharmaceutical companies in the scope of analysis and their efforts to curb antimicrobial resistance.

Learn more

View our detailed overview of each company’s performance in the Index, including breakdowns of their product portfolios and R&D pipelines.

Back to top |